Registered number
13183550
MEDICARE BUREAU LIMITED
Filleted Accounts
29 February 2024
MEDICARE BUREAU LIMITED
Registered number: 13183550
Balance Sheet
as at 29 February 2024
Notes 2024 2023
£ £
Current assets
Cash at bank and in hand 663 1,590
663 1,590
Creditors: amounts falling due within one year 3 (450) (666)
Net current assets 213 924
Total assets less current liabilities 213 924
Net assets 213 924
Capital and reserves
Called up share capital 1 1
Profit and loss account 212 923
Shareholders' funds 213 924
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Urfan MALIK
Director
Approved by the board on 21 November 2024
MEDICARE BUREAU LIMITED
Notes to the Accounts
for the year ended 29 February 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings over 50 years
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 0 0
3 Creditors: amounts falling due within one year 2024 2023
£ £
Non-equity preference shares - -
Bank loans and overdrafts - -
Obligations under finance lease and hire purchase contracts - -
Trade creditors - -
Amounts owed to group undertakings and undertakings in which the company has a participating interest - -
Taxation and social security costs - 216
Other creditors 450 450
450 666
MEDICARE BUREAU LIMITED 13183550 false 2023-03-01 2024-02-29 2024-02-29 VT Final Accounts April 2024 Urfan MALIK No description of principal activity 13183550 2022-03-01 2023-02-28 13183550 core:WithinOneYear 2023-02-28 13183550 core:ShareCapital 2023-02-28 13183550 core:RetainedEarningsAccumulatedLosses 2023-02-28 13183550 2023-03-01 2024-02-29 13183550 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 13183550 bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 13183550 bus:Director40 2023-03-01 2024-02-29 13183550 2 2023-03-01 2024-02-29 13183550 bus:FRS102 2023-03-01 2024-02-29 13183550 bus:FilletedAccounts 2023-03-01 2024-02-29 13183550 2024-02-29 13183550 core:WithinOneYear 2024-02-29 13183550 core:ShareCapital 2024-02-29 13183550 core:RetainedEarningsAccumulatedLosses 2024-02-29 13183550 2023-02-28 iso4217:GBP xbrli:pure